“Pushing the boundaries of clinical research to create a healthier future.”
Janet Flisak’s professional story is one of remarkable evolution, built on a foundation of compassion, intellectual rigor, and unshakable purpose. From her earliest days in critical care nursing to her current leadership in global clinical research, Janet has remained dedicated to one central mission: improving patient outcomes through data-driven innovation and operational excellence. Her career trajectory reflects not only her capacity to adapt and grow in a rapidly evolving industry but also her unwavering commitment to integrity, quality, and results. With over 35 years of professional experience—including more than two decades in high-impact clinical development roles—Janet continues to be a transformative force in pharmaceuticals, biotechnology, and regulatory strategy.
Janet’s journey into healthcare began at the bedside, where she provided direct patient care in high-acuity environments. It was here that she developed her deep understanding of the patient experience, a perspective that would shape her future approach to clinical research and drug development. This early exposure instilled in her a sense of urgency and responsibility that would carry through into her leadership roles. The lessons learned in critical care—the importance of timeliness, precision, and empathy—have remained a compass throughout her career.
Eager to expand her impact, Janet transitioned into medical and regulatory writing. Her work in this domain sharpened her analytical thinking and enhanced her ability to communicate complex clinical data clearly and persuasively. During this time, she authored and reviewed key clinical documents, including protocols, study reports, and regulatory submissions. This role was pivotal in merging her clinical acumen with scientific storytelling, a skill that proved invaluable as she assumed greater leadership responsibilities in clinical operations and development.
Janet’s ascent through the ranks of the life sciences industry is marked by strategic foresight and operational mastery. At organizations such as Janssen, GSK, and PRA, she assumed increasingly senior roles, overseeing international Phase 3 clinical trials and global project portfolios. Her work has spanned a broad range of therapeutic areas—from oncology and immunology to rare diseases—demonstrating not only versatility but also a keen understanding of disease-specific regulatory environments. Janet has consistently delivered trial outcomes that met rigorous regulatory standards while balancing patient safety and scientific integrity.
Throughout her executive leadership tenure, Janet has demonstrated an ability to navigate complex challenges with a calm, solution-oriented mindset. She has built and led high-performing global teams, fostering cultures rooted in accountability, compliance, and innovation. Whether managing multi-regional trial logistics, spearheading NDA/BLA submissions, or aligning cross-functional strategies, she brings a rare ability to unify vision with execution. Her tenure at Engrail Therapeutics and Advaxis Inc. is a testament to her capacity to align science and strategy in service of meaningful outcomes.
In addition to her corporate leadership, Janet is the founder of Flisak CMC Scientific Consulting, LLC, where she partners with clients across the life sciences sector to deliver strategic clinical development and regulatory solutions. Through this consultancy, she brings her decades of hands-on experience to emerging companies and established organizations alike, supporting their path to commercialization and growth. Her ability to distill complex regulatory landscapes into actionable strategies has made her a sought-after advisor in the field.
Beyond her professional achievements, Janet is an active contributor to education and community engagement. She currently serves on two school boards, including the Souderton Area School District and the Montgomery County Intermediate Unit, where she helps shape educational policy and governance. Her dedication to mentoring and collaboration underscores a lifelong commitment to empowering others, both within and outside of the healthcare industry. These roles reflect her belief in the power of knowledge-sharing and leadership by example.
Janet’s educational background includes dual Bachelor of Science degrees in Nursing and Business Administration, as well as an MBA in International and Global Studies. This multidisciplinary foundation enables her to bridge the gap between clinical insight and strategic business leadership. It also informs her global perspective—essential in an industry where cross-border coordination and international regulatory harmonization are critical to success.
Throughout her career, Janet has been invited to present on key topics in both education and pharmaceuticals. She is a confident communicator, capable of engaging diverse audiences ranging from regulatory authorities to corporate boards. While her work has frequently involved authoring pivotal regulatory documents, it is her ability to synthesize information, motivate teams, and drive toward shared goals that sets her apart as a leader.
Janet Flisak remains energized by the opportunity to contribute her expertise to organizations focused on innovation, ethics, and patient-centered outcomes. With a passion for mentoring, a keen strategic eye, and a lifelong dedication to public health, she is poised to add lasting value to any board or executive team she joins. Her legacy is defined not only by the trials she has led or the drugs she has helped bring to market, but also by the people and ideas she has championed along the way.
Character:
Janet demonstrates an unshakable commitment to integrity, patient advocacy, and servant leadership. Her career reflects a deep personal drive to uplift others and effect meaningful change. Whether in a boardroom or a clinical setting, she leads with empathy, purpose, and a sense of shared mission.
Knowledge:
She possesses a rare combination of deep clinical expertise, regulatory fluency, and operational insight. Her experience spans decades of hands-on involvement in trial design, compliance, and international project management. This breadth enables her to advise on both the micro-level details and the macro-level strategy of clinical development.
Strategic:
Janet’s ability to align vision with implementation is a hallmark of her leadership. She navigates complex regulatory pathways and cross-functional initiatives with clarity and discipline. Her strategic mindset ensures that innovation is not only envisioned but also executed with measurable impact.
Communication:
From presenting to global stakeholders to authoring regulatory dossiers, Janet excels in conveying critical information with precision and authority. Her narrative-driven leadership style helps inspire teams, foster trust, and ensure alignment across diverse collaborators. She understands that effective communication is the bridge between science, policy, and public health.
